Is There an Added Value of Dual-Time-Point [68Ga]Ga–Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings?
Akram Al-Ibraheem, Serin Moghrabi, Baraa Alsyouf, Marwah Abdulrahman, Mahd Al-Foqaha, Farah Al-Tameemi, Bara’ah Bashabsheh, Saad Ruzzeh, Dimah Khalid Jiad, Ahmed Firas Al-Hammouri, Hongcheng Shi, Ahmed Saad Abdlkadir, Asem Mansour · 2026
Read Is There an Added Value of Dual-Time-Point [68Ga]Ga–Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings? by Akram Al-Ibraheem, Serin Moghrabi, Baraa Alsyouf, Marwah Abdulrahman, Mahd Al-Foqaha, Farah Al-Tameemi, Bara’ah Bashabsheh, Saad Ruzzeh, Dimah Khalid Jiad, Ahmed Firas Al-Hammouri, Hongcheng Shi, Ahmed Saad Abdlkadir, Asem Mansour (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13296389.txt.
Description
Akram Al-Ibraheem and colleagues ask, in 2026, whether scanning patients twice with a fibroblast-targeting tracer helps separate cancer from harmless uptake. The tracer lights up tissue around many tumours, and a delayed second scan has been proposed to sharpen the call.
Across varied cancers, uptake did shift between early and late scans, but accuracy in telling malignant from benign findings did not meaningfully improve. Early imaging alone matched the two-scan approach while saving time and easing workflow. The authors recommend a single early scan for routine practice with this tracer.
Catalog record
| CREATOR | Akram Al-Ibraheem, Serin Moghrabi, Baraa Alsyouf, Marwah Abdulrahman, Mahd Al-Foqaha, Farah Al-Tameemi, Bara’ah Bashabsheh, Saad Ruzzeh, Dimah Khalid Jiad, Ahmed Firas Al-Hammouri, Hongcheng Shi, Ahmed Saad Abdlkadir, Asem Mansour |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35061 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |